Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

被引：0
|
作者：
Heinz Reichmann
Andrew Lees
José-Francisco Rocha
Diogo Magalhães
Patrício Soares-da-Silva
机构：
[1] University of Dresden,Department of Neurology
[2] Reta Lila Weston Institute,University College London
[3] BIAL – Portela & CA S.A,Global Parkinson’s Disease Department
[4] BIAL – Portela & CA S. A,Research and Development Department
[5] da Siderurgia Nacional,Department of Pharmacology and Therapeutics
[6] Faculty of Medicine,MedInUP, Center for Drug Discovery and Innovative Medicines
[7] University Porto,undefined
[8] University Porto,undefined
来源：
Translational Neurodegeneration | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
相关论文
共 50 条
  • [21] Influence of levodopa daily dose on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study
    Carrolla, Camille
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 268 - 268
  • [22] Opicapone in Clinical Practice in Parkinson's UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study
    Lees, A.
    Reichmann, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 783 - 783
  • [23] Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: Findings from the OPTIPARK study
    Reichmann, Heinz
    Lees, Andrew
    Fonseca, Miguel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 283 - 283
  • [24] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: Findings from the real-world OPTIPARK study
    Jost, Wolfgang
    Reichmann, Heinz
    Lees, Andrew
    Marinho, Daniela
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 276 - 276
  • [25] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: findings from the real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S214 - S214
  • [26] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: findings from the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S228 - S229
  • [27] Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: findings from the OPTIPARK study
    Reichmann, H.
    Lees, A.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S230 - S232
  • [28] An open-label investigation of lamotrigine in Parkinson's patients with motor fluctuations
    Reider, CR
    Rienerth, JED
    Hubble, JP
    Paulson, GW
    NEUROLOGY, 1998, 50 (04) : A279 - A279
  • [29] Influence of disease duration in the Opicapone effectiveness in Parkinson's patients: real-world OPTIPARK study
    Warnecke, T.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 904 - 904
  • [30] Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson's Disease Patients with Motor Fluctuations
    Reichmann, Heinz
    Eggert, Karla
    Oehlwein, Christian
    Warnecke, Tobias
    Lees, Andrew J.
    Kemmer, Michael
    Soares-da-Silva, Patricio
    EUROPEAN NEUROLOGY, 2022, 85 (05) : 389 - 397
12345